1. Pfreundschuh MG, Ho A, Wolf M, et al. Treatment results of CHOP-21, CHOEP-21, MACOP-B and PMitCEBO with and without rituximab in young good-prognosis patients with aggressive lymphomas: Rituximab as an "equalizer" in the MinT (MABTHERA International Trial Group) study. Proc Am Soc Clin Oncol. 2005;23:567s. Abstract 6529.
2. Wilson WH, Porcu P, Hurd D, et al. Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103. Proc Am Soc Clin Oncol. 2005;23:567s. Abstract 6530.作者: guijinqiang 时间: 2014-5-25 22:35
谢谢分享!